Procardia XL

Adult Dosing .

Dosage forms:  ER TAB: 30 mg, 60 mg, 90 mg

angina, vasospastic

[30-90 mg PO qd]

Start: 30-60 mg PO qd, may incr. dose q7-14 days; Max: 90 mg/day; Info: do not cut/crush/chew tab; taper dose gradually to D/C

angina, chronic stable

[30-90 mg PO qd]

Start: 30-60 mg PO qd, may incr. dose q7-14 days; Max: 90 mg/day; Info: do not cut/crush/chew tab; taper dose gradually to D/C

HTN

[30-90 mg PO qd]

Start: 30-60 mg PO qd, may incr. dose q7-14 days; Max: 120 mg/day; Info: do not cut/crush/chew tab; taper dose gradually to D/C

high altitude pulmonary edema (off-label)

[30 mg PO q12h]

Start: 24h before ascent; Info: for prevention and tx; do not cut/crush/chew tab; D/C 5 days after peak arrival or upon descent

Raynaud phenomenon (off-label)

[30-60 mg PO qd]

Start: 30 mg PO qd, may incr. dose q7-14 days; Max: 120 mg/day; Info: do not cut/crush/chew tab; taper dose gradually to D/C

pulmonary arterial HTN (off-label)

[120-240 mg/day PO divided qd-bid]

Start: 30 mg PO qd; Max: 240 mg/day; Info: for pts w/ positive vasoreactivity test; do not cut/crush/chew tab; taper dose gradually to D/C

renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

hepatic dosing

[see below]

hepatic impairment: not defined, caution advised

Peds Dosing .

Dosage forms:  ER TAB: 30 mg, 60 mg, 90 mg

pulmonary arterial HTN (off-label)

[2-3 mg/kg/day PO divided qd-bid]

Start: after establishing effective dose w/ IR form; Max: 180 mg/day; Info: for pts w/ positive vasoreactivity test; do not cut/crush/chew tab; taper dose gradually to D/C

renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

hepatic dosing

[see below]

hepatic impairment: not defined, caution advised